FDA Warns Pfizer Over Its Failure To Swiftly Report Adverse Events

摘要

In a likely omen of an increasingly tough regulatory future for drugmakers, the FDA has sharply rebuked Pfizer over its failure to promptly notify the agency of serious adverse events associated with some of the company's top-selling drugs.rnThe May 26 warning letter obtained by WDL said Pfizer has delayed reporting complaints associated with some of its drugs for a long time and the tardiness has been growing in recent years.